No evidence for involvement of genetic variants in the x-linked neuroligin genes NLGN3 and NLGN4X in probands with autism spectrum disorder on high functioning level

American Journal of Medical Genetics, Part B: Neuropsychiatric Genetics

Volumn 147, Issue 4, 2008, Pages 535-537

  Wermter, Anne Kathrin ^a   Kamp Becker, Inge ^a   Strauch, Konstantin ^a   Schulte Körne, Gerd ^a,b   Remschmidt, Helmut ^a  

^a PHILIPPS UNIVERSITY MARBURG   (Germany)

^b UNIVERSITY OF MUNICH   (Germany)

Author keywords

Asperger syndrome; Autism spectrum disorder; Neuroligin 3; Neuroligin 4; X chromosome

Indexed keywords

NEUROLIGIN;

AMINO ACID SUBSTITUTION; ARTICLE; ASPERGER SYNDROME; AUTISM; CHILD; DNA POLYMORPHISM; FEMALE; GENE; GENE MUTATION; GENETIC VARIABILITY; HETEROZYGOTE; HUMAN; MAJOR CLINICAL STUDY; MALE; NLGN3 GENE; NLGN4X GENE; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; X CHROMOSOME;

ASPERGER SYNDROME; AUTISTIC DISORDER; CARRIER PROTEINS; CHILD; DNA MUTATIONAL ANALYSIS; HUMANS; MEMBRANE PROTEINS; NERVE TISSUE PROTEINS; POLYMORPHISM, GENETIC;

EID: 45149128206     PISSN: 15524841     EISSN: 1552485X     Source Type: Journal    
DOI: 10.1002/ajmg.b.30618     Document Type: Article

References (23)

1. Bacchelli E, Maestrini E. 2006. Autism spectrum disorders: Molecular genetic advances. Am J Med Genet Part C 142C:13-23.
2. Baron-Cohen S, Knickmeyer RC, Belmonte MK. 2005. Sex differences in the brain: Implications for explaining autism. Science 310:819-823.
3. Blasi F, Bacchelli E, Pesaresi G, Carone S, Bailey AJ, Maestrini E. 2006. Absence of coding mutations in the X-linked genes neuroligin 3 and neuroligin 4 in individuals with autism from the IMGSAC collection. Am J Med Genet Part B 141B:220-221.
4. Chih B, Afridi SK, Clark L, Scheiffele P. 2004. Disorder-associated mutations lead to functional inactivation of neuroligins. Hum Mol Genet 13:1471-1477.
5. Dean C, Dresbach T. 2006. Neuroligins and neurexins: Linking cell adhesion, synapse formation and cognitive function. Trends Neurosci 29:21-29.
6. Dudbridge F. 2003. Pedigree disequilibrium tests for multilocus haplotypes. Genet Epidemiol 25:115-121.
7. Fombonne E. 2005. Epidemiology of autistic disorder and other pervasive developmental disorders. J Clin Psychiatry 66 (Suppl 10):3-8.
8. Gauthier J, Bonnel A, St-Onge J. 2005. NLGN3/NLGN4 gene mutations are not responsible for autism in the Quebec population. Am J Med Genet Part B 132B:74-75.
9. Hinney A, Schmidt A, Nottebom K, Heibult O, Becker I, Ziegler A, Gerber G, Sina M, Gorg T, Mayer H, Siegfried W, Fichter M, Remschmidt H, Hebebrand J. 1999. Several mutations in the melanocortin-4 receptor gene including a nonsense and a frameshift mutation associated with dominantly inherited obesity in humans. J Clin Endocrinol Metab 84:1483-1486.
10. Jamain S, Quach H, Betancur C, Rastam M, Colineaux C, Gillberg IC, Soderstrom H, Giros B, Leboyer M, Gillberg C, Bourgeron T. Paris Autism Research International Sibpair Study. 2003. Mutations of the X-linked genes encoding neuroligins NLGN3 and NLGN4 are associated with autism. Nat Genet 34:27-29.
11. Laumonnier F, Bonnet-Brilhault F, Gomot M. 2004. X-linked mental retardation and autism are associated with a mutation in the NLGN4 gene, a member of the neuroligin family. Am J Hum Genet 74:552-557.
12. Le Couteur A, Rutter M, Lord C, Rios P, Robertson S, Holdgrafer M, McLennan J. 1989. Autism diagnostic interview: A standardized investigator-based instrument. J Autism Dev Disord 19:363-387.
13. Lord C, Risi S, Lambrecht L, Cook EH Jr, Leventhal BL, DiLavore PC, Pickles A, Rutter M. 2000. The autism diagnostic observation schedule-generic: A standard measure of social and communication deficits associated with the spectrum of autism. J Autism Dev Disord 30:205-223.
14. Rubenstein JL, Merzenich MM. 2003. Model of autism: Increased ratio of excitation/inhibition in key neural systems. Genes Brain Behav 2:255-267.
15. Tager-Flusberg H, Joseph RM. 2003. Identifying neurocognitive phenotypes in autism. Phil Trans R Soc Lond 358:303-314.
16. Talebizadeh Z, Bittel DC, Veatch OJ, Butler MG, Takahashi TN, Miles JH. 2004. Do known mutations in neuroligin genes (NLGN3 and NLGN4) cause autism? J Autism Dev Disord 34:735-736.
17. Talebizadeh Z, Lam DY, Theodoro MF, Bittel DC, Lushington GH, Butler MG. 2006. Novel splice isoforms for NLGN3 and NLGN4 with possible implications in autism. J Med Genet 43:e21.
18. Vincent JB, Kolozsvari D, Roberts WS, Bolton PF, Gurling HM, Scherer SW. 2004. Mutation screening of X-chromosomal neuroligin genes: No mutations in 196 autism probands. Am J Med Genet Part B 129B:82-84.
19. Volkmar FR, Lord C, Bailey A, Schultz RT, Klin A. 2004. Autism and pervasive developmental disorders. J Child Psychol Psychiatry 45:135-170.
20. Vorstman JA, Staal WG, van Daalen E, van Engeland H, Hochstenbach PF, Franke L. 2006. Identification of novel autism candidate regions through analysis of reported cytogenetic abnormalities associated with autism. Mol Psychiatry 11(1):18-28.
21. World Health Organisation. 1993. The ICD-10 classification of mental and behavioural disorders: Clinic descriptions and diagnostic guidelines. WHO: Geneva.
22. Yan J, Oliveira G, Coutinho A. 2005. Analysis of the neuroligin 3 and 4 genes in autism and other neuropsychiatric patients. Mol Psychiatry 10:329-332.
23. Ylisaukko-oja T, Rehnstrom K, Auranen M, Vanhala R, Alen R, Kempas E, Ellonen P, Turunen JA, Makkonen I, Riikonen R, Nieminen-von Wendt T, von Wendt L, Peltonen L, Jarvela I. 2005. Analysis of four neuroligin genes as candidates for autism. Eur J Hum Genet 13:1285-1292.